Island Pharmaceuticals Limited
ILA.AX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$96.23M
Close$
$0.05
85.4% downside
Current Fair Value
85.4% downsideOvervalued by 85.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $96.23 Million |
|---|---|
| Enterprise Value | $83.36 Million |
| Earnings per Share | $-0.04 |
| Beta | 0.12 |
| Outstanding Shares | 295,916,682 |
Return
| Return on Equity | -102.27% |
|---|---|
| Return on Assets | -98.34% |
| Return on Invested Capital | -108.28% |
Valuation & Multiples
| P/E Ratio | -9.03 |
|---|---|
| PEG | -8.14 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 701.04 |
| Enterprise Value to EBIT | -5.72 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Island Pharmaceuticals Limited
0CEO: David Charles Foster
Island Pharmaceuticals Limited functions as a pharmaceutical enterprise dedicated to drug discovery and repurposing, with a specific focus on creating preventative or therapeutic solutions for viral infections. Its lead therapeutic agent...